Commentary on: Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries

被引：0
|
作者：
Juste Aristide Goungounga
Roch Giorgi
机构：
[1] Aix Marseille Univ,
[2] INSERM,undefined
[3] IRD,undefined
[4] SESSTIM,undefined
[5] Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale,undefined
[6] APHM,undefined
[7] Hôpital de la Timone,undefined
[8] Service Biostatistique et Technologies de l’Information et de la Communication,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：791 / 793
页数：2
相关论文
共 50 条
  • [1] Commentary on: Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries
    Goungounga, Juste Aristide
    Giorgi, Roch
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (04) : 791 - 793
  • [2] Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries
    Alix Augustin
    Steven Le Gouill
    Rémy Gressin
    Aurélie Bertaut
    Alain Monnereau
    Anne-Sophie Woronoff
    Brigitte Trétarre
    Patricia Delafosse
    Xavier Troussard
    Anne Moreau
    Olivier Hermine
    Marc Maynadié
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 629 - 635
  • [3] Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries
    Augustin, Alix
    Le Gouill, Steven
    Gressin, Remy
    Bertaut, Aurelie
    Monnereau, Alain
    Woronoff, Anne-Sophie
    Tretarre, Brigitte
    Delafosse, Patricia
    Troussard, Xavier
    Moreau, Anne
    Hermine, Olivier
    Maynadie, Marc
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (04) : 629 - 635
  • [4] Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
    Clémentine Sarkozy
    Loïc Chartier
    Vincent Ribrag
    Remy Gressin
    Christian H. Geisler
    Hanneke C. Kluin-Nelemans
    Catherine Thieblemont
    Franck Morschhauser
    François Lemonnier
    Violaine Safar
    Benoît Tessoulin
    Lucie Oberic
    Ghandi Damaj
    Hervé Ghesquières
    Krimo Bouabdallah
    René Olivier Casasnovas
    Roch Houot
    Wolfram Klapper
    Barbara Burroni
    Christiane Pott
    Marie-Hélène Delfau-Larue
    Elizabeth Macintyre
    Mary Callanan
    Mats Jerkeman
    Michael Unterhalt
    Eva Hoster
    Martin Dreyling
    Steven Le Gouill
    Olivier Hermine
    Morgane Cheminant
    Blood Cancer Journal, 15 (1)
  • [5] Clinical Efficacy of the Rivbd Combination for Refractory/Relapsed (R/R) Mantle Cell Lymphoma (MCL) Patients: A Retrospective Study of the French Lysa Group
    Regny, Caroline
    Malak, Sandra
    Manson, Guillaume
    Sarkozy, Clementine
    Clavert, Aline
    Herbaux, Charles
    Chauchet, Adrien
    Jourdan, Eric
    Sanhes, Laurence
    Godmer, Pascal
    Pascal, Laurent
    Le Du, Katell
    Sutton, Laurent
    Voillat, Laurent
    Dupuis, Jehan
    Anglaret, Bruno
    Gressin, Remy
    BLOOD, 2016, 128 (22)
  • [6] Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study - JCOG0108A
    Kinoshita, Tomohiro
    Watanabe, Takashi
    Itoh, Kuniaki
    Yoshimura, Kenichi
    Tobinai, Kensei
    Ogura, Michinori
    Yamaguchi, Motoko
    Kurosawa, Mitsutoshi
    Imaizumi, Yoshitaka
    Ota, Shuichi
    Kaba, Harumi
    Mukai, Kiyoshi
    Nakamura, Shigeo
    Ohshima, Koichi
    Hotta, Tomomitsu
    Tsukasaki, Kunihiro
    Nagai, Hirokazu
    Shimoyama, Masanori
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2021, 61 (01) : 35 - 41
  • [7] A National Cancer Database Study of Survival Trends in Patients with Mantle Cell Lymphoma Stratified By Age Group
    Wang, Jacqueline F.
    Zhou, Jihao
    Hwang, Steven R.
    Diefenbach, Catherine S.
    Ruan, Jia
    Martin, Peter
    Paludo, Jonas
    Munoz, Javier L.
    Ansell, Stephen M.
    Witzig, Thomas E.
    Habermann, Thomas M.
    Cerhan, James R.
    Nowakowski, Grzegorz S.
    Wang, Yucai
    BLOOD, 2023, 142
  • [8] Clinical Benefit for Patients with Non-Small Cell Lung Cancer Enrolled in Phase I Trials
    Levy, Antonin
    Gomez-Roca, Carlos
    Massard, Christophe
    Planchard, David
    Albiges, Laurence
    Bahleda, Ratislav
    Bourgier, Celine
    Deutsch, Eric
    Soria, Jean Charles
    Besse, Benjamin
    ONKOLOGIE, 2013, 36 (06): : 357 - 362
  • [9] Quantification of intratumor heterogeneity derived from baseline FDG PET/CT in untreated mantle cell lymphoma patients enrolled in a prospective phase III trial of the LYSA group: preliminary results
    Carlier, Thomas
    Bailly, Clement
    Hatt, Mathieu
    Kraeber-Bodere, Francoise
    Visvikis, Dimitris
    Le Gouill, Steven
    Bodet-Milin, Caroline
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [10] A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172)
    Kouroukis, C. Tom
    Fernandez, Louis A. V.
    Crump, Michael
    Chua, Neil Sun
    Buckstein, Rena
    Turner, Robert
    Assouline, Sarit
    Klasa, Richard J.
    Walsh, Wendy
    Powers, Jean
    Eisenhauer, Elizabeth
    LEUKEMIA & LYMPHOMA, 2011, 52 (03) : 394 - 399
12345